Shin Nippon Biomedical Laboratories, Ltd.

Shin Nippon Biomedical Laboratories, Ltd.

9.60
USD
+2.60
(+37.14%)
0.87EPS
Jan 29Next Earn

Important Dates

Shin Nippon Biomedical Laboratories Ltd.'s next confirmed earnings release is scheduled for January 29, 2027.

Earnings Date1/29/2027

Share Statistics

As of September 30, 2026, Shin Nippon Biomedical Laboratories Ltd. has 41.63M shares outstanding.

Shares Outstanding41.63M

Financial Position

As of September 30, 2026, Shin Nippon Biomedical Laboratories Ltd. maintains a current ratio of 1.25, meaning it holds 1.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 122.58, indicating elevated leverage, while an interest coverage ratio of 10.86 demonstrates strong ability to service its debt obligations.

Current Ratio1.25
Quick Ratio0.62
Debt / Equity122.58
Debt / EBITDA11.73
Interest Coverage10.86

Financial Efficiency

USD

Over the twelve months ended September 30, 2026, Shin Nippon Biomedical Laboratories Ltd. posted a return on equity (ROE) of 14.75, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 3.60 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 5.69, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 7.29, useful for judging operating efficiency across full business cycles. The company generates approximately 149,622.47 in revenue per employee across its workforce of 1,500.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 1.18 indicates how many times Shin Nippon Biomedical Laboratories Ltd. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Equity (ROE)14.75
Return on Assets (ROA)5.69
Return on Invested Capital (ROIC)3.60
Return on Capital Employed (ROCE)7.29
Revenue Per Employee149,622.47
Employee Count1,500.50
Inventory Turnover1.18

Taxes

USD

Over the twelve months ended September 30, 2026, Shin Nippon Biomedical Laboratories Ltd. recorded 14.27M in income tax expense. That works out to an effective tax rate of 28.36, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 50.30M, leaving 36.25M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

Income Tax14.27M
Effective Tax Rate28.36

Stock Price Statistics

As of the close on October 28, 2026, Shin Nippon Biomedical Laboratories Ltd.'s stock has gained approximately 2.56% over the past 52 weeks.

52-Week Price Change2.56%

Income Statement

USD

Over the twelve months ended September 30, 2026, Shin Nippon Biomedical Laboratories Ltd. generated 224.51M in revenue and converted that into 36.25M in net income, yielding earnings per share of 0.87. EBITDA reached 26.44M, while operating income came in at 26.44M.

Revenue224.51M
Gross Profit116.46M
Operating Income26.44M
Pretax Income50.30M
Net Income36.25M
EBITDA26.44M
EBIT26.44M
Earnings Per Share (EPS)0.87

Balance Sheet

USD

As of September 30, 2026, Shin Nippon Biomedical Laboratories Ltd. holds 155.07M in cash and equivalents against 310.20M in total debt, resulting in a net debt position of 150.29M. Total book value stands at 250.78M, with working capital of 61.99M providing operational flexibility.

Cash & Cash Equivalents155.07M
Total Debt310.20M
Net Debt150.29M
Equity (Book Value)250.78M
Book Value Per Share6.02
Working Capital61.99M

Margins

Over the twelve months ended September 30, 2026, Shin Nippon Biomedical Laboratories Ltd. posted a gross margin of 51.87, reflecting its pricing power and cost economics. The operating margin of 11.78 and net profit margin of 16.15 provide insight into operational efficiency.

Gross Margin51.87
Operating Margin11.78
Pretax Margin22.41
Profit Margin16.15
EBITDA Margin11.78

Stock Splits

Shin Nippon Biomedical Laboratories Ltd.'s most recent stock split took place on September 27, 2005 with a 1:2 split ratio.

Last Split Date9/27/2005
Split Ratio1:2